You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

September 7, 2021

Chandavya Ing Writes about Dependent Patents in Southeast Asia for les Nouvelles Journal

Chandavya Ing, an associate in the intellectual property group of Tilleke & Gibbins’ Phnom Penh office, coauthored an article titled “The Fate of Dependent Patents in Cambodia, Laos, Myanmar, Thailand, and Vietnam—A Comparison with the Situation in Germany and India” with Prof. Dr. Heinz Goddar, a patent attorney and partner in the Munich office of Boehmer & Boehmer. The article appeared in the September 2021 issue of les Nouvelles, the journal of the Licensing Executives Society International (LESI).

Dependent patents are new patents that also rely on a previous one, such as when an invention builds on or adds new technology to a previous patented invention. This approach to securing commercial rights for progressive inventions is often seen in patent-heavy fields such as telecommunications and advanced technology. Commercializing a dependent patent without infringing the earlier patent (i.e., the one that it depends on) requires licensing from the holder of the earlier patent. If this proves unworkable, the dependent patent cannot go to market. While this may ensure that the original patent rights are upheld, such an impasse can also block innovation and progress.

As the authors explain in the article, Germany and India (as well as other countries such as Russia and Taiwan) will enlist a state party in an effort to resolve any such situation that arises, often through a de-blocking mechanism such as a compulsory or non-voluntary license. The article then looks in detail at the de-blocking mechanisms and provisions in the legal and regulatory environment of various countries in Southeast Asia, before offering comparison to the situation in Germany and India.

Overall, the authors conclude that a more active (but balanced) use of compulsory licensing—which already exists in many Southeast Asian countries but is not frequently employed outside of the pharmaceutical sector—might help clear patent-related obstacles to further technological development in patent-heavy fields, thus enabling technology transfer that would benefit Southeast Asian countries’ economies and technological development.

The full article is available on the LESI website (subscription required).

RELATED INSIGHTS​ 

July 8, 2022
On July 7, 2022, Nopparat Lalitkomon, senior associate, and Gvavalin Mahakunkitchareon, associate of the firm’s corporate and commercial group collaborated with Microfocus and CyberRes in hosting a webinar entitled “ PDPA: Managing and Minimizing Data Protection Risks.” In this online session, the speakers covered the following items: Overview of the Personal Data Protection Act 2019; Roles and responsibilities of data controllers or data processors; Rights of data subjects; and Updates on new subregulations under the Personal Data Protection Act (PDPA).
June 20, 2022
On June 17, 2022, two attorneys in the firm’s corporate and commercial group in Bangkok—Charuwan Charoonchitsathian, partner, and Gvavalin Mahakunkitchareon, associate—were keynote speakers for a special focus session organized by the Thailand office of Plug and Play Tech Center. During the session, Charuwan and Gvavalin walked attendees through the latest legal developments applicable to innovative technologies in the smart cities sector, including: Artificial intelligence (AI), cloud services, and internet of things (IOT); Data protection updates from the recent PDPA public hearings; and Evolving cybersecurity regulations. The Plug and Play Tech Center in Bangkok is the local branch of global startup ecosystem and innovation hub helping entrepreneurs gain access to expertise, guidance, and structural support needed to grow their business. For more information, please see the Plug and Play Tech Center website.
June 15, 2022
On June 23–24, 2022, two attorneys from Tilleke & Gibbins’ corporate and commercial group—senior associate Nopparat Lalitkomon and associate Thammapas Chanpanich—will attend the HOOK Conference 2022 to lead a session on implementation of and compliance with Thailand’s Personal Data Protection Act (PDPA), which came into effect on June 1, 2022. The HOOK Conference 2022 is a Southeast Asian-centric conference on performance marketing, featuring over 25 curated sessions presented by high-profile speakers and attendees from leading companies and organizations across the region. The conference will be held at the Bangkok Marriott Marquis Queen’s Park. The event will address a wide range of topics, such as industry and technical updates, channels and platforms, data-driven decision-making, marketing considerations in ASEAN, and the role of influencers. To learn more about the event, please visit the conference website.
June 8, 2022
On June 7, 2022, Tilleke & Gibbins’ Bangkok and Vietnam offices collaborated with other regional members of the Lifesciences Asia-Pacific Network (LAN) to present a webinar on data protection regulations across several Asia-Pacific jurisdictions—particularly in relation to the life sciences and healthcare sector. In the first half of this high-engagement session, Nopparat Lalitkomon, senior associate in the firm’s corporate and commercial group in Bangkok, was joined by top data privacy experts from Australia, China, and Japan as the speakers provided a comprehensive update on key legal developments in personal data protection in each jurisdiction. In the second half of the presentation, Waewpen Piemwichai, senior associate in the firm’s corporate and commercial group in Vietnam, participated in a panel discussion together with the rest of the speakers to compare noteworthy aspects of data privacy laws in Vietnam and other Asia-Pacific jurisdictions, including India. Tilleke & Gibbins is a founding member of LAN, which brings together eight leading life sciences law firms from across the Asia-Pacific region to provide clients with a one-stop shop for support and guidance on legal and regulatory needs across the life sciences sector, covering human, animal, and crop health along with food, animal feed, medical devices, cosmetics, and hazardous substances.